Clinical Trial Update: A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating niraparib in previously treated metastatic esophageal, gastroesophageal junction, and proximal gastric adenocarcinoma was terminated,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Shadia Jalal, MD | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-06-04